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KEPENTINGAN KEHADIRAN PUNCAK PADA ZON 2 KAPILARI 
ELEKTROFORESIS (CE) DALAM MENGESAN KEWUJUDAN HEMOGLOBIN 
CONSTANT SPRING. 
ABSTRAK 
Hemoglobin Constant Spring adalah defek pada titik mutasi bagi α-talasemia di “termination 
codon” dan menyebabkan penyambungan pada rantaian α dan mengurangkan kestabilan 
mRNA.  Ia merupakan α-talassemia jenis “non deletional” yang biasa dan lazim dijumpai di 
kebanyakan negara-negara Asia Tenggara. Hemoglobin yang abnormal ini mempunyai 
kepelbagaian dan variasi dari aspek klinikal dan boleh berinteraksi dengan α° dan 
menyebabkan kewujudan Hemoglobin H- Constant Spring.  
 
Pemeriksaan hemoglobin yang abnormal ini dilakukan menggunakan kapilari elektroforesis. 
Kapilari elektroforesis ini merupakan salah satu teknik pemisahan analisis dan boleh 
digunakan untuk memisahkan dan mengkuantitatifkan Hemoglobin A₂, Hemoglobin F dan 
hemoglobin abnormal yang lain. Ia adalah kaedah yang sensitif untuk mengesan kewujudan 
Hemoglobin Constant Spring di mana ia akan memberikan kehadiran puncak pada zon 2 di 
kapilari elektroforesis. 
 
Tujuan kajian ini dilakukan adalah untuk menentukan kepentingan kehadiran puncak pada 
zon 2 kapilari elektroforesis dalam mendiagnosis Hemoglobin Constant Spring, 
membandingkan profil hematologi di antara genotip Hemoglobin Constant Spring yang 
berlainan dan juga untuk menentukan lingkungan nilai di zon 2 pada kapilari elektroforesis 
untuk genotip Hemoglobin Constant Spring yang berlainan. 
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Satu kajian keratan rentas telah dilakukan daripada Julai 2015 sehingga Julai 2016 dengan 
mengumpul secara rawak sebanyak 137 sampel yang menunjukkan kehadiran puncak pada 
zon 2 kapilari elektroforesis. Sampel-sampel ini telah diuji untuk parameter-parameter sel 
darah merah (Hb, RBC, MCV,MCH dan RDW) dengan menggunakan automasi Sysmex XN 
3000,”Sysmex Corporation, USA. Analisis hemoglobin dilakukan menggunakan kapilari 
elektroforesis (Sebia CAPILLARYS2 Flex Piercing Sebia, PN 1227, France) dan analisis 
DNA menggunakan “Multiplex PCR” dan “ARMS” dilakukan untuk “deletional” dan “non 
deletional” α talassemia.   
 
Daripada 137 sampel, 118 sampel (86.1%) yang menunjukkan puncak pada zon 2 kapilari 
elektroforesis telah diuji positif untuk mutasi pada “termination codon” Hemoglobin 
Constant Spring. Majoriti sampel yang diuji adalah jenis heterozigot Hemoglobin Constant 
Spring iaitu 92 (67.2%), diikuti oleh kompaun heterozigot iaitu 22 sampel (16%) dan 
homozigot iaitu sebanyak 4 sampel (2.9%).  
 
Terdapat bilangan sampel yang menunjukkan puncak positif pada Zon 2 kapilari 
elektroforesis yang signifikan dan juga positif untuk mutasi pada “termination codon” 
Hemoglobin Constant Spring. Julat nilai Hemoglobin Constant Spring untuk genotip 
heterozigot adalah di antara min 0.67±0.27%. Manakala untuk julat nilai Hemoglobin 
Constant Spring bagi genotip homozigot dan kompaun heterozigot adalah masing-masing di 
antara 4.5 hingga 5.5 % dan 0.3 hingga 2.2%.  Melalui kajian ini, terdapat perbezaan 
parameter hematologi yang ketara di antara ketiga-tiga genotip yang berlainan iaitu 
heterozigot, kompaun heterozigot dan homozigot Hemoglobin Constant Spring. Oleh itu, 
kita boleh membezakan ketiga-tiga kumpulan ini melalui parameter-parameter hematologi 
dan nilai Hemoglobin Constant Spring pada puncak zon 2 di kapilari elektroforesis sekiranya 
tiada analisis molekular disediakan atau tidak dapat diakses di mana-mana pusat/kemudahan. 
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SIGNIFICANCE OF ZONE 2 PEAK ON CAPILLARY ELECTROPHORESIS FOR 
THE DETECTION OF HAEMOGLOBIN CONSTANT SPRING 
ABSTRACT 
Haemoglobin Constant Spring (Hb CS) is a point mutational defect of α thalassaemia at the 
termination codon and leads to α chain extension and reduced mRNA stability.   It is a 
prevalent and common non deletional α thalassemia in most Southeast Asian countries. This 
abnormal haemoglobin has clinical heterogeneity and can interact with α° and cause non 
deletional Hb H CS.  
 
Screening for this abnormal haemoglobin is performed by capillary electrophoresis (CE). It 
is one of the analytical separation techniques and can be used to separate and quantitate Hb 
A2, Hb F and other abnormal haemoglobins. CE gives peak at the Zone 2 for Hb CS and it is 
a sensitive method to detect Hb CS. 
 
The aims of this study were to determine the significance of presence of Zone 2 peak on CE 
in diagnosing Hb CS, to compare the haematological profiles between different Hb CS 
genotypes and to estimate range for Zone 2 peak by CE with different Hb CS genotypes.  
 
A cross sectional study was done from July 2015 to July 2016 by collecting 137 samples 
randomly which showed positive peak on Zone 2 of CE. The samples were tested for red cell 
indices (Hb, RBC, MCV, MCH, and RDW) by using Sysmex XN 3000 analyzer, Sysmex 
Corporation, USA. Haemoglobin analyses were performed using CAPILLARYS2 Flex-
Piercing System Sebia, PN 1227, France and DNA analyses using Multiplex PCR and 
ARMS were done for non deletional and deletional α thalassaemia. 
xvi 
 
One hundred and eighteen (86.1%) out of 137 samples that showed positive peak in Zone 2 
of CE, were positive for termination codon Hb CS mutation, confirmed by molecular 
analysis. The most common types of Hb CS found was Heterozygotes Hb CS which was 92 
samples (67.2%), followed by compound heterozygotes which was 22 samples (16%) and 
homozygotes group which was 4 samples (2.9%).  
 
There were significant number of samples that had positive peak at Zone 2 which confirmed 
for termination codon CS mutation. The range of Hb CS level for Hb CS trait can be 
estimated to lie within mean of 0.67±0.27%. Meanwhile, the range of Hb CS level for 
compound heterozygotes Hb CS and homozygotes Hb CS were from 0.3 to 2.2 % and 4.5 to 
5.5%, respectively. This might aid in making the diagnosis if the molecular technique is not 
available.  
 
Significant haematological differences which include Hb level, MCV, MCH, RDW, RBC 
count and Hb CS level were observed between heterozygotes, homozygotes and compound 
heterozygotes Hb CS. Consequently, we will able to predict these groups from the 
haematological indices and Hb CS level/ quantification on zone 2 peak if the molecular 
technology is not available.  
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1.0 GENERAL INTRODUCTION 
Haemoglobin (Hb) Constant Spring (CS) is a non deletional alpha (α) thalassaemia on α2 
genes as a result of impaired RNA translation consequent on a termination codon mutation 
leading to an elongated messenger ribonucleic acid (mRNA) and α globin chain. This variant 
contains point mutation at the termination codon, in which the defect is (TAA>CAA) and it 
is associated with reduced mRNA stability and elongation of α chain. This point mutation 
leads to α chain extension up to another 31 amino acid residues (Laig et al., 1990). 
 
α thalassaemia is highly prevalent in Malaysia and its neighbouring Southeast Asian 
countries. It is a public health concern in Malaysia, with a gene frequency of 4.1%. On the 
other hand, Hb CS occurs with a frequency of 1-4% in most Southeast Asian countries and 
1-6% in Malaysia. (Ahmad et al., 2013) 
 
The abnormal Hb in CS leads to unstable mRNA and cause decrease in rate of α globin chain 
synthesis. The heterozygote of Hb CS have normal clinical and haematological features but 
if compared to deletional alpha plus (α+) thalassaemia, the heterozygous states of non 
deletional forms are sometimes associated with mild hypochromic anaemia. Meanwhile, the 
homozygotes show clinical presentation similar as thalassaemia intermedia with mild 
anaemia, jaundice and presence of hepatosplenomegaly. However the interaction of the Hb 
CS gene with deletional α thalassaemia is usually more severe than deletional Hb H disease 
in which some of the patients are dependent to transfusion (Liao et al., 2010). 
 
Screening for this abnormal haemoglobin is performed by capillary electrophoresis (CE). It 
is one of the analytical separation techniques that had been widely used in clinical 
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laboratories (Petersen et al., 2003). The CE system can be used to separate and quantitate Hb 
A2, Hb F and other abnormal haemoglobin. 
 
CE will give peak at the Zone 2 for Hb CS. Other common variant that shares the same peak 
as Hb CS is Hb Paksé. The incidence of Hb Paksé can also be observed at a significant 
prevalence but might have been underestimated. This is possibly due to misidentifying the 
cases as Hb CS (Viprakasit et al., 2002) . Hb Paksé also has similar clinical presentation as 
Hb CS. However, the prevalence of this type of variant has not been described in Malaysia 
previously. Other rare variants that can give similar peak in Zone 2 of CE are Hb C, Hb F-
Texas, Hb C-Harlem, variant de Hb A₂ “Setif” and other rare haemoglobins (Sebia, 2013). 
 
This study was done to determine the significance of presence of Zone 2 peak on CE in 
diagnosing Hb CS. Since Hb CS is prevalent in this region and shows clinical heterogeneity, 
hence reliable detection of Hb CS by CE can be used for further management of patients 
with this type of haemoglobinopathy in centres that do not have access to molecular studies. 
In addition, we hope with this study, different types of Hb CS can be predicted if the 
molecular technique is not available. 
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2.0 LITERATURE REVIEW 
 
2.1 HAEMOGLOBIN GENETICS 
 
A normal haemoglobin molecule is made up by haem and globin in which the former is 
responsible for oxygen transport while the latter serves to protect haem from oxidation. The 
synthesis of globin chain is characterized by two switches. As early as 5 weeks of gestation, 
the embryonic haemoglobin switches to fetal haemoglobin and the synthesis completed by 
week 10. Although expression of beta (β) globin occurs early, around 8 weeks but the β 
globin synthesis is still low with a high up regulation just before birth, correlating with a 
decrease in γ globin expression. This indicates the replacement of fetal haemoglobin by adult 
haemoglobin (A. Victor Hoffbrand, 2011) (as shown in Table 2.1). 
 
Table2.1. Haemoglobins normally present during adult, fetal and embryonic periods of life  
Haemoglobin species Globin chains Period when normally 
present 
A α₂β₂ Major haemoglobin in adult 
life 
A2 α₂δ₂ Minor haemoglobin in adult 
life 
F α₂ γ₂ Minor haemoglobin in adult 
life, major haemoglobin in 
fetal life with a declining 
percentage through the 
neonatal period 
Gower 1 ζ₂ε₂ Significant haemoglobin 
during early intrauterine life 
Gower 2 α₂ε₂ Significant haemoglobin 
during early intrauterine life 
Portland ζ₂ γ₂ Significant haemoglobin 
during early intrauterine life 
Adapted from (Bain, 2006). 
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The genes encoding the α and β chain are located on the chromosome 16 and chromosome 
11 respectively. Cis-acting enhancer sequences control the tissue specific expression, which 
is located upstream at each gene cluster (Steinberg et al., 2009).  Only a single β gene is 
present while two α genes are present on each chromosome. Thus, it generates more complex 
hereditary patterns (Giordano, 2013). The synthesis of α and β globin chains take place in 
erythroid precursors to the reticulocyte stage (Higgs, 1993). 
 
2.2 INTRODUCTION OF THALASSAEMIA 
 
2.2.1 Definition 
Thalassaemia: an inherited heterogeneous disorder of haemoglobin synthesis that results in a 
diminished rate of synthesis of the haemoglobin or haemoglobins (Bain, 2006). 
 
α thalassaemia: a group of thalassaemias characterized by absent or reduced rate of α globin 
chain production, commonly resulting from the deletion of one or more of the α globin 
genes, less often it results from the mutation of locus control genes or genes encoding trans-
acting factors or altered structure of an α gene (Bain, 2006). 
 
Haemoglobinopathy: an inherited disorder resulting from the synthesis of a structurally 
abnormal haemoglobin or also can be used to include group of thalassaemias with reduced 
rate of synthesis of one of the globin chains (Bain, 2006). 
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2.2.2  Background and incidence of α thalassaemia 
The name of ‘thalassaemia’ was given by Whipple and Bradford in 1936. It is derived from 
Greek word, sea. In 1925, Cooley and Lee were the first person that described this condition 
(Weatherall et al., 2006). Four α globin genes present in normal individuals and they are 
linked as pairs, α2 and α1, at the tip of each chromosome 16(A. Victor Hoffbrand, 2016).  In 
α thalassaemia, it is commonly result from the deletion of a large part or the entire gene. Non 
deletional α thalassaemia also can occur as a result from the mutations of the α2 gene (αTα 
thalassaemia) or the α1 gene (ααT thalassaemia). Hence, α thalassaemia can be divided 
broadly into deletional and non deletional thalassaemia (Harteveld and Higgs, 2010). 
 
α thalassaemia also can be classified as alpha zero (α°) thalassaemia in which no α chains are 
produced from both linked pairs or reduced production of α chain from the affected 
chromosome, known as α+. The α° thalassaemia are caused by deletion of both α globin 
genes and the deletions vary in size and commonly associated with geographical area (as 
shown in Figure 2.1). In Southeast Asia, the commonest α° are alpha zero Southeast Asian 
type deletion (--
SEA
) and alpha zero thalassaemia Mediterranean type deletion (--
MED
) 
(Harteveld and Higgs, 2010). 
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Figure 2.1. The α globin gene cluster deletions that underlie α° thalassaemia. The yellow 
colour represent extent of each deletion and green colour represent regions of uncertainty. 
Adapted from (A. Victor Hoffbrand, 2016). 
 
Deletion of one of the normal four α globin genes will result in α+ thalassaemia (-α/αα). 
There are three homologous sub-segments which are referred as X, Y and Z (as shown in 
Figure 2.2).The commonest α+ thalassaemia in Malaysia are α plus thalassaemia 3.7 (α-3.7) 
and α plus thalassaemia 4.2 (-α4.2). α-3.7 is the rightward deletion in which there is 
misalignment and recombination between the Z segments while -α4.2 is leftward deletion in 
which there is crossover between the X boxes which are 4.2kb apart (A. Victor Hoffbrand, 
2016). 
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Figure 2.2. The molecular mechanism that underlie the deletion forms of α+ thalassaemia 
(a) normal cluster showing X, Y and Z homology boxes 
(b) 3.7-kb deletion 
(c) 4.2-kb deletion 
Adapted from Weather and Clegg 2001 (A. Victor Hoffbrand, 2016). 
 
Another genetic problem that affects the α globin gene is point mutation that results in 
partially or completely inactivation of one of the α genes. 
 
2.2.3  Pathophysiology of α thalassaemia 
Clinically, for both forms of α thalassaemia can be broadly categorized into four syndromes 
and this depends on the number of functional α globin gene affected (as shown in Figure 
2.3). Severe forms of α thalassaemia known as Hb Bart’s hydrop fetalis or α thalassaemia 
major (--/--) and this syndrome occurs when all four genes are deleted or dysfunction. This 
syndrome is incompatible with extrauterine life (Harteveld and Higgs, 2010). 
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When only one functional α globin gene is inherited, it results in Hb H disease or also known 
as α thalassaemia intermedia (--/-α). This is usually the result of the compound heterozygous 
state for α0 and α+ thalassemia (Ahmad et al., 2013). Patient with Hb H disease presented 
with variable severity of chronic haemolytic anaemia. It is characterized by greatly reduced 
rate of synthesis of the α chain and imbalance and excess of β chain production leads to the 
formation of an abnormal haemoglobin with β chain tetramers which referred to as Hb H. 
This Hb H is unstable and precipitates in erythroblasts and results in intramedullary cell 
death or also referred to as ineffective erythropoiesis (A. Victor Hoffbrand, 2016). 
 
The third syndrome is α thalassaemia minor or also known as α thalassaemia trait. It is 
characterized by cis or trans positional loss of two α genes, resulting in heterozygosity for α0 
thalassemia (--/αα) and homozygosity for α+ thalassemia (-α/-α). The individuals who inherit 
these genes defect usually are asymptomatic with mild hypochromic microcytic anaemia. 
Silent carriers with three functional genes (-α/αα) normally exhibit no clinical abnormalities 
with normal to mild changes in red cell indices (Ahmad et al., 2013). 
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Figure 2.3. The genetics of α thalassaemia. Adapted from (A. Victor Hoffbrand, 2016). 
 
Data from Malaysian Department of Statistics in 2010 showed that Malaysian population 
was about 28.3 million people. Malays and other Bumiputera comprised of 67.4% followed 
by Chinese, 24.6%, Indians 7.3% and others of 0.7% (Department of Statistics Malaysia, 
2011). There is no new statistics data available onwards. 
 
High prevalence of α thalassaemia was found in Malaysia and Southeast Asian countries. 
The gene frequency of α thalassaemia in Malaysia is 4.1% (Rahimah et al., 2012). The gene 
frequencies in other neighbouring countries such as Indonesia were from 2.7-11% for α° and 
α+ thalassemia (Nainggolan et al., 2003), Thailand of 20-30% (Kanokpongsakdi et al., 2007) 
and Philipines of 2.6-3.2%  (Ko et al., 1999).  
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2.3 INTRODUCTION AND BACKGROUND OF HAEMOGLOBIN 
CONSTANT SPRING 
Hb CS is one of the most prevalent non deletional α thalassaemia in Southeast Asia. Non 
deletional α thalassaemia can be broadly classified according to the type of mutations 
affected. Types of mutations described by Bain in 2006 are: 
a. Ribonucleic acid (RNA) splice site mutation in α1 or α2 gene 
b. RNA polyadenylation signal mutations 
c. Impaired RNA translocation consequent on initiation codon or initiation 
consensus sequence mutation 
d. Impaired RNA translation consequent on a frame shift or nonsense 
mutation 
e. Impaired RNA translation consequent on a termination codon mutation 
leading to an elongated mRNA and α globin chain 
f. Production of highly unstable α chain as a result of point mutation or a 
small deletion 
g. Lack of transactivating factor encoded by the α thalassaemia mental 
retardation x-linked (ATRX) gene 
 
Hb CS results from mutation of a termination codon at the α2 gene which leads to an 
elongated α chain. This added another 31 amino acids to the normal α-globin sequence. 
Mutation at the termination codon at the α2 globin gene results in unstable mRNA and 
produce an α thalassaemia 2- like effect. Mostly, the documented cases of non-deletional 
thalassaemia are often caused by mutation of the α2 gene than of the α1 gene. A patient with 
mutation in the α2 gene has more severe phenotype compared to those patient who inherit α2 
gene deletions (Bain, 2006). 
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The mRNA of alpha Constant Spring (αCS)  only accounts for less than 1% of protein output 
of a normal α2 gene but it is very unstable compared with normal α mRNA. Fascinatingly, in 
terms of pathophysiology, the synthesis of even small amounts of elongated αCS results in 
more severe anaemia than is seen in deletional α-thalassaemia. The mechanism behind this 
had been proposed that αCS chains may have harmful effects on cellular and membrane 
properties of red blood cells with Hb CS (Bunn and Forget, 1986). 
 
In 1997, Schrier et al studied the unusual pathobiology of Hb CS red blood cells. They found 
that the Hb CS-containing red blood cells were distinctly overhydrated relative to deletional 
α-thalassaemia variants. The derangement of volume regulation and cell hydration occured 
early in erythroid maturation and was fully expressed at the reticulocyte stage. They also 
found that the membrane rigidity and membrane mechanical stability of Hb CS-containing 
red blood cells was increased when compared with Hb H and α-thalassemia-1 trait red blood 
cells. They had suggested and concluded that the membrane pathology of Hb CS variants 
was caused by combination of the deleterious effects induced by membrane oxidized by αCS 
and β globin chains (Schrier et al., 1997). 
 
Hb CS can be inherited as heterozygotes, homozygotes or combination with other 
thalassaemia variants and recognized as compound heterozygotes. The individuals in 
heterozygotes group are clinically and haematologically normal. Meanwhile, the 
homozygotes can resemble thalassaemia intermedia with mild anaemia and presence of 
hepatosplenomegaly. Interaction of Hb CS such as with α thalassaemia 1 deletion can lead to 
Hb H-CS disease (-/αCSα). Individuals with Hb H-CS are clinically more severe than 
deletional Hb H disease. In some cases, the individuals can become transfusion dependent 
and also reported the incidence of Hb H-CS hydrops fetalis (Liao et al., 2010). 
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The multi ethnic migrations and interactions can lead to interaction of Hb CS with other 
thalassaemia variants, such as co-inheritance of β thalassaemia or interaction of Hb CS with 
Hb E which is quite prevalent in Southeast Asian countries (Fucharoen et al., 2003). 
   
2.3.1  Prevalence and incidence of Haemoglobin Constant Spring 
Hb CS is the most prevalent of mutational α thalassaemia in Southeast Asian countries. The 
gene frequencies of Hb CS vary between 1 to 8% (Fucharoen and Winichagoon, 1992).  
 
Rahimah et al in 2013 had collected data from the Insitute of Medical Research (IMR) 
regarding the distribution of α thalassaemia gene variants in diverse ethnic populations in 
Malaysia. They retrieved the haematological and molecular data from more than 5000 
patients referred from all hospitals and centres in Malaysia for α thalassaemia screening to 
IMR from year 2007 till 2010.  
 
Three common non deletional mutations identified were Hb Adana, Hb Quong Sze and Hb 
CS. Hb CS is the most common non deletional thalassaemia compared to the other two types 
of mutational α thalassaemia identified. In Malays and Sabahans, it is the third common α 
thalassaemia determinants. Orang Asli aborigines recorded the highest incidence of Hb CS 
with incidence of 11.5% meanwhile the Malaysian Chinese recorded the lowest incidence of 
0.7% (Ahmad et al., 2013). 
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2.4 LABORATORY TECHNIQUES FOR THE IDENTIFICATION OF 
THALASSAEMIA/ HAEMOGLOBINOPATHIES 
To diagnose thalassaemia and haemoglobinopathies, it requires combination of laboratory 
techniques. At least two techniques must be done with the assessment of the results must 
correlated with the clinical findings and background ethnicity of the patients (Bain, 2006). 
 
Venous blood will be taken and collected in ethylene diamine tetra-acetic acid (EDTA) as 
anticoagulation. It should be stored at temperature of 4
°
C and should be tested within a week. 
Storage longer than one week will affect the result as it will lead to denaturation of 
haemoglobin. Request for haemoglobin analysis for thalassaemia must be accompanied by 
proper identification name, age, ethnicity, clinical information as well as family history 
(Bain, 2006). 
 
International Committee for Standardization in Haematology expert panel on thalassaemia 
and haemoglobinopathy had made recommendations for diagnostic laboratory investigations 
for these conditions. Initial tests recommended were full blood count (FBC), haemoglobin 
electrophoresis at alkaline pH, sickling test and quantification of abnormal Hb A₂ and Hb F 
(Clarke and Higgins, 2000). 
 
2.4.1 Full blood count and peripheral blood film 
Initially, samples for haemoglobin analysis for thalassaemia either α or β or haemoglobin 
variants must be tested for FBC and smear must be done to check for red cell morphology. If 
a full blood picture shows polychromasia, a reticulocyte count is indicated. Other than that, 
FBC is initially done for thalassaemia screening (Ministry of Health Malaysia, 2009). 
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The thalassaemia screening is done to identify carriers of thalassaemia or 
haemoglobinopathy disorders. Pre test counselling is carried out for both groups (voluntary 
or index case group) before the FBC is taken. The level of mean cell haemoglobin (MCH) of 
<27 pg had been chosen before subjected the individuals for further test such as haemoglobin 
analysis (Ministry of Health Malaysia, 2009). 
 
MCH is preferably selected as a cut-off point for thalassaemia screening as the parameter is 
less susceptible to storage changes compared to mean cell volume (MCV). MCV is also 
raised by a number of conditions such as having concurrent vitamin B12 or folate 
deficiencies or in HIV patients who is taking nucleoside analogues due to impaired 
deoxyribonucleic acid (DNA) synthesis (Howard et al., 2005). 
 
Other parameter in FBC that can help in distinguishing thalassaemia from nutritional 
anaemia (such as iron deficiency anaemia) as the latter also can present with hypochromic 
microcytic anaemia is red cell distribution width (RDW). RDW is a measure of the degree of 
variation in red cell size and may provide useful information to support the diagnosis but 
cannot be used as a single indicator. In iron deficiency anaemia, the RDW is increased as 
presence of anisopoikilocytosis while in thalassaemia, it produces uniform microcytic red 
cells, thus the RDW is not increased (Clarke and Higgins, 2000). 
 
The haemoglobin cannot be used as a sole indicator to diagnose thalassaemia and 
haemoglobinopathy as in haemoglobin variant or minor α thalassaemia, the individuals can 
have normal or slightly low haemoglobin (Clarke and Higgins, 2000). 
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In Thailand, a study had been done to evaluate the effectiveness of the automated 
haematology analyzer for thalassaemia screening using URIT-2900 haematology analyzer. 
The suitable cut off  MCV and MCH had been determined in which 78 fl and 27pg 
respectively for screening of α°thalassaemia, β thalassaemia and Hb E (Karnpean et al., 
2011). 
 
Full blood picture can also give clue in aiding the diagnosis of thalassaemia and 
haemoglobinopathy. In case of beta (β) thalassaemia, there is hypochromic microcytic 
picture with anisopoikilocytosis. Meanwhile in Hb CS particularly in heterozygotes group, 
the individuals might have mild hypochromic microcytic anaemia and some can have normal 
red cell parameters (Bain, 2006). 
 
2.4.2 Haemoglobin H inclusion test (brilliant cresyl blue test or new 
methylene blue test) 
This is a technique for the demonstration of Hb H inclusions when there is a suspicion of Hb 
H disease or when there is presence of H band on the haemoglobin electrophoresis. Brilliant 
cresyl blue is an oxidant in which it will precipitates in the red cells when it is mixed with 
the Hb H. Hb H is unstable and when it precipitates it gives the small blue staining inclusion 
that is evenly distributed and gives the appearance of golf ball appearance (Hartwell et al., 
2005) (as shown in Figure 2.4). 
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Figure 2.4. Haemoglobin Inclusion test showing golf ball appearance. Adapted from (Moss, 
2011). 
 
2.4.3  Haemoglobin electrophoresis 
Haemoglobin electrophoresis is still the most common technique for initial detection of 
thalassaemia and haemoglobinopathies although new modalities are available such as high 
performance liquid chromatography (HPLC) or CE (Ager and Lehmann, 1958). 
 
It is carried out on a filter paper, a cellulose acetate membrane at alkaline pH or citrate or 
agarose gel at acidic pH. It is must be performed on lysed packed cells and not whole blood 
as the latter will have interference with presence of paraprotein or high concentration of 
19 
 
polyclonal immunoglobulins, in which can lead to a prominent band which can be confused 
with haemoglobin variant (Bain, 2006). 
 
The principles of haemoglobin electrophoresis is based on when the proteins are applied to a 
membrane and exposed to charge gradient, the band separated from each other and the 
separation of the bands can be visualized by staining with either haem or protein stain. 
Initially the haemoglobin electrophoresis will be done at alkaline pH as it will detect the 
presence of Hb A, S/D/G/ Lepore, F, A2,C,E,O-Arab and H as well Hb CS. Each test must be 
run together with control samples containing Hb A,S,F and C (Bain, 2006). 
 
Hb CS is unstable haemoglobin, therefore there is no specific band on haemoglobin 
electrophoresis as it can present at any areas. If variant haemoglobin is detected after initial 
test with haemoglobin electrophoresis at alkaline pH, it is essential to confirm the variant by 
other technique such as running the haemoglobin electrophoresis at an acidic pH by using 
citrate or agarose gel. Other modalities to confirm the presence of abnormalities also must be 
performed by either using HPLC or CE (Clarke and Higgins, 2000). 
 
2.4.4  High performance liquid chromatography (HPLC) 
To detect haemoglobin abnormalities, HPLC is a sensitive and precise method (Ou et al., 
1983). HPLC is one of the available methods of choice for initial screening for haemoglobin 
variants which is also suitable for neonatal screening as it can quantify Hb A, Hb A2 and Hb 
F (Eastman et al., 1996). 
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HPLC utilises a weak cation exchange column in which it is a process of cumulation of 
molecules (normal and variant hemoglobins) and separation into different fractions by their 
adsorption onto a negatively charged stationary phase in a chromatography column, followed 
by their elution by a mobile phase. The mobile phase contains liquid with incrementing 
concentrations of cations flowing through the column. The cations will compete with the 
adsorbed proteins for the anionic binding sites. As a result, the adsorbed positively charged 
haemoglobin molecules are eluted from the column at a rate cognate to their affinity in the 
stationary phase into the liquid phase (Bain, 2006). 
 
Different types of haemoglobin give peaks at a particular retention time. The area under the 
retention time are quantified and plotted on the chromatogram. It is an automated system and 
is primarily indicated for the measurement of HbA2 and HbF but it also provides retention 
times for several haemoglobin variants (Brants, 2011). 
 
Although many haemoglobin variants can be separated from each other, some of the variant 
can overlap with each others. The advantages of using HPLC compared to the haemoglobin 
electrophoresis are it is an automated system and rapid with high precision. It is less labour 
intensive and required small sample to run with. Moreover, it can quantify normal and 
variant haemoglobins such as in case of β thalassaemia carier, it can quantify percentage of 
Hb A₂ level (George et al., 2001). 
  
The disadvantages of using HPLC are greater reagent cost and it requires technical expertise. 
Furthermore, variant haemoglobin may have same retention times as normal haemoglobin. 
For example, Hb Lepore may overlap with Hb A₂ on the chromatogram. Hb A₂ also cannot 
be accurately quantified in the presence of Hb S and Hb E as a result of glycated Hb S and E 
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co-eluting with Hb A₂. However, HPLC accurately quantifies Hb A₂ in the presence of Hb C 
(Greene et al., 2012). 
 
Hb Bart and Hb H elute in the void volume (pre-calibration peak) and only can be 
distinguished when the levels are higher than 5%. Certain artefacts such as bilirubin also can 
interfere in the void volume and may lead to a sharp peak in the same retention area as Hb H, 
Hb Bart and acetylated Hb F. Hb CS elute in the Hb C window with the retention time of 
4.90-5.30. Hb O-Arab also elute in the same window (Greene et al., 2012). Hb CS gives a 
very small peak at the C window and sometimes can be missed (Pornprasert et al., 2015). 
 
2.4.5  Capillary electrophoresis (CE) 
2.4.5 (a) History 
Hjerten in 1967 was the first person who described electrophoretic separation of molecules 
in a glass tube and subsequent detection of the separated components by using ultraviolet 
absorption (Hjertén, 1967). The idea was unpopular until in 1981, Jorgenson and Lucaks 
introduced the high resolution power of capillary zone electrophoresis (Jorgenson and 
Lukacs, 1981). In years afterwards, many advances have applied the principles such as 
systemic analysis of proteins, genomics as well as for thalassaemia and 
haemoglobinopathies. The CE system was approved by USA Food and Drug Administration 
in 2007 for the evaluation of haemoglobinopathies (Keren et al., 2008).  
 
 
 
 
22 
 
2.4.5 (b) Principles, background and results 
All CE techniques are carried out using similar apparatus (Bosserhoff and Hellerbrand, 
2005): 
- A high voltage power supply 
- The anode and cathode buffer reservoirs 
- The separation chamber (capillary tube) 
- The injection system 
- The detector 
 
For analysis of thalassaemia and haemoglobinopathies, it uses similar principles as other CE, 
by using free solution. Charged molecules are separated by their electrophoretic mobility in 
alkaline buffer with a specific pH. Other separation factors are electrolyte pH and and 
electroosmotic flow. It is an automated analyzer in which the assay is performed on the 
haemolysate of whole blood samples that had been collected in EDTA tubes as an 
anticoagulant.  A complete haemoglobin profile is conducted in which it quantifies fractions 
of normal haemoglobin (Hb A, A₂ and F) as well as detects the major haemoglobin variants 
such as Hb C,E ,S and D (Sebia, 2013). 
 
The Capillarys 2 Flex Piercing instruments can allow 8 simultaneous analyses functioning in 
parallel. First, a sample is diluted with haemolysing solution and by aspiration; it is injected 
at the anodic end of capillary. Protein separations at a high voltage is then performed and 
direct detection of haemoglobin is made at the cathodic end of the capillary at an absorbance 
wave length of 415 nm. The resulting electrophoregrams are evaluated visually for pattern 
abnormalities (Sebia, 2013). 
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Different haemoglobin variants are identified in zones Z1 to Z15. Hb A₂ is identified in Zone 
3 while Hb A is found in Zone 9 (as shown in Figure 2.5).  For Hb CS, it is identified in 
Zone 2 of capillary electrophoresis or also known as Zone C (as shown in Figure 2.6). Other 
haemoglobin variants that share the same position as Hb CS are Hb Paksé (which is reported 
to be found in Thailand), Hb C, Hb A₂ variant and other types of rare haemoglobin variants. 
 
Figure 2.5. Electrophoregram of normal sample: normal haemoglobin fractions. Adapted 
from Manual of Capillarys Haemoglobin (E) using the Capillarys 2 Flex-Piercing 
Instrument, 2013/01. 
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Figure 2.6. Electrophoregram of Hb CS at Zone 2 of capillary electrophoresis. Adapted from 
Manual of Capillarys Haemoglobin (E) using the Capillarys 2 Flex-Piercing Instrument, 
2013/01. 
 
Appropriate sample collection and storage is very important as it can interfere with the 
results. Fresh anticoagulated whole blood samples collected in EDTA bottle are 
recommended. The samples should only be stored up to seven days between 2°C to 8°C. The 
reason behind this is progressive degradation of haemoglobin might occur. Apart from that, 
when the age of sample is longer than seven days, it may interfere with the results. For 
example, “aging fraction” of Hb A will appear more anodic, which is in Zone 11 despite the 
usual zone identified which is in Zone 9 (Sebia, 2013). 
 
Suwannakan et al in 2011 had published a multicentre validation of fully automated CE for 
diagnosis of thalassaemia and haemoglobinopathies in Thailand. It was conducted in four 
different reference laboratories. The performance characteristics including precision and 
accuracy had been analysed and compared with existing validated HPLC and automated 
cation exchange low pressure liquid chromatography (LPLC). Comparison of the three 
methods performed to assess accuracy of Hb A₂ and F showed good linear correlation. It 
